Ultragenyx Pharmaceutical
RARE
RARE
301 hedge funds and large institutions have $2.87B invested in Ultragenyx Pharmaceutical in 2025 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 131 increasing their positions, 91 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 309 → 301 (-8)
16% less capital invested
Capital invested by funds: $3.42B → $2.87B (-$551M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
301
Holding in Top 10
4
Calls
$88.2M
Puts
$33.9M
Top Buyers
| 1 | +$140M | |
| 2 | +$55.9M | |
| 3 | +$46.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$33.6M |
| 5 |
JP Morgan Chase
New York
|
+$22.5M |
Top Sellers
| 1 | -$61.3M | |
| 2 | -$59.5M | |
| 3 | -$49.1M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$46.6M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$36.8M |
